Decreased Serum Thrombospondin-1 Levels in Pancreatic Cancer Patients Up to 24 Months Prior to Clinical Diagnosis: Association with Diabetes Mellitus.
about
Novel circulating peptide biomarkers for esophageal squamous cell carcinoma revealed by a magnetic bead-based MALDI-TOFMS assay.Updated therapeutic outcome for patients with periampullary and pancreatic cancer related to recent translational research.Detection of early pancreatic ductal adenocarcinoma with thrombospondin-2 and CA19-9 blood markers.A competing endogenous RNA network identifies novel mRNA, miRNA and lncRNA markers for the prognosis of diabetic pancreatic cancer.Proteomic strategies in the search for novel pancreatic cancer biomarkers and drug targets: recent advances and clinical impact.Advances in mass spectrometry-based cancer research and analysis: from cancer proteomics to clinical diagnostics.The impact of diabetes mellitus on survival following resection and adjuvant chemotherapy for pancreatic cancer.Association of breast carcinoma growth with a non-canonical axis of IFNγ/IDO1/TSP1.Analysis of the plasma proteome using iTRAQ and TMT-based Isobaric labeling.Recent advances in proteomic profiling of pancreatic ductal adenocarcinoma and the road ahead.[Early stage pancreatic cancer].Biliary Obstruction: Endoscopic Approaches.Validation of Biomarkers for Early Detection of Pancreatic Cancer: Summary of The Alliance of Pancreatic Cancer Consortia for Biomarkers for Early Detection Workshop.Proteomic biomarkers in body fluids associated with pancreatic cancer.Signal-Targeted Therapies and Resistance Mechanisms in Pancreatic Cancer: Future Developments Reside in Proteomics.
P2860
Q35963403-9B641605-0B0F-45D5-9065-785D5AB0979FQ37538915-E8B1627F-9FC9-4129-8584-2EA8D7D85BDDQ38682057-6D952094-65A7-4C78-8CE7-C789D59C9761Q38714217-755301A2-68AF-48EA-AD6D-C7E7A0B3DE8DQ38777938-7BBE6906-9546-4008-9013-B6FDFE3F60ABQ38816181-D3245E71-C9AF-44FA-BBDA-439D024862A6Q39432270-A1E0B580-EC40-466F-8668-485E7DA630A9Q47127514-B398588A-AEAD-4025-BB3F-0F57E2B8D4ABQ47421750-78FBCFD2-7B99-42BF-9792-56D34454BB33Q47659096-37432E9D-B081-4632-8E5C-9DD54F61BACFQ49630827-66B94CAD-7EA3-46D8-9C5A-8D0CCE5D4325Q49711742-599DA10A-2523-4242-BCBE-544E25EDF1BCQ49966087-C8A2D895-02BD-4E1B-9944-34FB3AAC407AQ52584324-0BDA5F3F-DD5D-44C9-B956-038FA7ACCC1AQ54977145-189BB953-A488-4E1F-9E5C-2154135C44A1
P2860
Decreased Serum Thrombospondin-1 Levels in Pancreatic Cancer Patients Up to 24 Months Prior to Clinical Diagnosis: Association with Diabetes Mellitus.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Decreased Serum Thrombospondin ...... iation with Diabetes Mellitus.
@ast
Decreased Serum Thrombospondin ...... iation with Diabetes Mellitus.
@en
type
label
Decreased Serum Thrombospondin ...... iation with Diabetes Mellitus.
@ast
Decreased Serum Thrombospondin ...... iation with Diabetes Mellitus.
@en
prefLabel
Decreased Serum Thrombospondin ...... iation with Diabetes Mellitus.
@ast
Decreased Serum Thrombospondin ...... iation with Diabetes Mellitus.
@en
P2093
P2860
P50
P1476
Decreased Serum Thrombospondin ...... iation with Diabetes Mellitus.
@en
P2093
B Kevin Park
Claire Jenkinson
Darragh P O'Brien
Evangelia-O Fourkala
Fiona Campbell
Ian J Jacobs
John F Timms
Lucy Oldfield
Robert Sutton
Rosalind E Jenkins
P2860
P304
P356
10.1158/1078-0432.CCR-15-0879
P407
P50
P577
2015-11-16T00:00:00Z